基础医学与临床 ›› 2026, Vol. 46 ›› Issue (9): 1267-1271.doi: 10.16352/j.issn.1001-6325.2026.09.1267

• 临床研究 • 上一篇    下一篇

28例肠系膜脂膜炎患者的临床特征及诊疗分析

陆君阳1, 刘安雷2, 周慷3, 王强4, 肖胤勃5, 戴佳原6*, 沈敏6,7*   

  1. 中国医学科学院北京协和医学院 北京协和医院 1.基本外科;2.急诊科;3.放射科;4.消化内科;5.病理科;6.罕见病医学科;7.风湿免疫科,北京 100730
  • 收稿日期:2026-05-26 修回日期:2026-06-26 出版日期:2026-09-05 发布日期:2026-08-18
  • 通讯作者: *daijiayuan1@pumch.cn; shenmpumch@163.com
  • 基金资助:
    中国医学科学院医学与健康科技创新工程项目(2024-I2M-C&T-B-014);疑难重症及罕见病全国重点实验室开放研究课题(2025-O-ZD-005);北京协和医院中央高水平医院临床科研专项(2025-PUMCH-D-006)

Analysis of clinical characteristics, diagnosis and management in 28 cases of mesenteric panniculitis

LU Junyang1, LIU Anlei2, ZHOU Kang3, WANG Qiang4, XIAO Yinbo5, DAI Jiayuan6*, SHEN Min6,7*   

  1. 1. Department of General Surgery; 2. Department of Emergency; 3. Department of Radiology; 4. Department of Gastroenterology; 5. Department of Pathology; 6. Department of Rare Diseases; 7. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
  • Received:2026-05-26 Revised:2026-06-26 Online:2026-09-05 Published:2026-08-18
  • Contact: *daijiayuan1@pumch.cn; shenmpumch@163.com

摘要: 目的 总结肠系膜脂膜炎(MP)的临床特点以进一步提高对该病的认识。方法 回顾性分析北京协和医院2015年1月至2026年1月明确诊断肠系膜脂膜炎的住院患者,分析患者的临床特征及治疗情况。结果 共纳入28例病例,男性13例(46.4%),女性15例(53.6%),平均年龄为(58.1±10.9)岁。腹痛是最常见的主诉(96.4%),其次是腹胀(14.3%)、发热(10.7%)、恶心呕吐(3.6%)和腹泻(3.6%)。18例患者(64.3%)接受激素治疗,其中7例为激素联合免疫抑制治疗,4例为激素联合生物制剂治疗,1例接受激素联合他莫昔芬(抗雌激素)治疗。4例患者接受外科手术,2例切除肠系膜病变,术后3月出现复发。随访期间,18例患者病情稳定,1例单用糖皮质激素治疗的患者对治疗无反应,1例停药后复发,2例失访。结论 MP是一种慢性炎症性疾病。患者常以腹痛为主要症状,在正确诊断和治疗后预后通常良好。本研究旨在为提高临床医生对肠系膜脂膜炎的认识提供依据,以避免误诊或漏诊。

关键词: 肠系膜脂膜炎, 腹痛, 计算机断层扫描, 糖皮质激素

Abstract: Objective To summarize the clinical characteristics of mesenteric panniculitis (MP) in order to further enhance the understanding of this disease. Methods Retrospective analysis was conducted on hospitalized patients with a definite diagnosis of mesenteric panniculitis at Peking Union Medical College Hospital from January 2015 to January 2026. The clinical characteristics and treatment status of the patients were analyzed. Results A total of 28 patients were included. There were 13 males (46.4%) and 15 females (53.6%), with a mean age of (58.14±10.87) years. Abdominal pain was the most common chief complaint (96.4%), followed by abdominal distension(14.3%), fever (10.7%), nausea and vomiting (3.6%), and diarrhea (3.6%). Eighteen patients (64.3%)received corticosteroid therapy, among whom 7 received corticosteroids combined with immunosuppressive therapy,4 received corticosteroids combined with biologic agents, and 1 received corticosteroids combined with tamoxifen.Four patients underwent surgery; two of them had mesenteric lesion resection but experienced recurrence three months postoperatively. During follow-up, 18 patients remained stable, one patient treated with corticosteroid immunotherapy showed no response, one relapsed after drug discontinuation, and two were lost to follow-up. Conclusions MP is a chronic inflammatory disease. Patients typically present with abdominal pain as the predominant symptom, and the prognosis is generally favorable after accurate diagnosis and appropriate treatment. This study aims to provide a basis for improving clinicians′ understanding of mesenteric panniculitis, in order to avoid misdiagnosis or missed diagnosis.

Key words: mesenteric panniculitis, abdominal pain, computed tomography, corticosteroid

中图分类号: